Strategic partnerships Hardy Diagnostics has active and recent partnerships with NEMIS Technologies and Gradientech, signaling openness to distribution and rapid-detection collaborations. This suggests sales opportunities in co-marketing, channel partnerships, and joint go-to-market initiatives for rapid on-site pathogen detection and FDA-classified devices.

Expansion potential With a growth-focused profile recognized by Inc. Magazine and ongoing product introductions like Enrichment Broth for Candida auris and CompactDry TCR, there is momentum for expanding into new microbiology workflows and regional markets, offering cross-sell of media, enrichment broths, and instrument-compatible consumables.

Regulatory strength FDA-licensed manufacturing and ISO 13485 certification position Hardy Diagnostics as a compliant supplier of medical microbiology products, enabling cross-border sales and partnership discussions with institutions and distributors requiring rigorously certified diagnostics and quality systems.

Public sector traction Recent GSA MAS award and government-focused procurement history indicate established relationships with public sector buyers, suggesting expansion opportunities in federal, state, and municipal labs for media, reagents, and diagnostic solutions.

Technology-enabled selling A tech stack including iCIMS, WordPress, Adobe Experience Cloud, and data tools implies readiness for digital channels, lead nurturing, and e-commerce or enabled catalog sales, enabling targeted campaigns to microbiology labs, hospitals, and teaching institutions seeking reliable culture media and rapid detection solutions.